GIARDIA LAMBLIA - ANVISA Registration 82890930004

Access comprehensive regulatory information for GIARDIA LAMBLIA in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 82890930004 and manufactured by R-BIOPHARM AG. The registration is held by R-BIOPHARM BRASIL COMERCIO DE PRODUTOS PARA ANALISE DE ALIMENTOS LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including EPITOPE DIAGNOSTICS, INC., R-BIOPHARM AG, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
82890930004
Registration Details
ANVISA Registration Number: 82890930004
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

RIDASCREEN® Giardia
Risk Class II

Registration Details

82890930004

25351457886202496

67272757000296

Company Information

R-BIOPHARM AG
Germany
PT: ALEMANHA

Dates and Status

Feb 17, 2025

VIGENTE

09/18/2025 19:00:01